EKSO Company Profile and Key Details

Q: Who are the executives of EKSO?

Mr. Scott W. DavisChief Executive OfficerMr. Anthony PrattVice President of SalesMs. Ann CooksonHR DirectorMs. Foon Lim ChweePres of APACMr. Jason C. JonesChief Operating OfficerMr. Steven A. ShermanChairman & Chief Executive OfficerMr. Stephan AderholdSenior Vice President & GM of EMEAMr. Scott G. DavisChief Executive Officer & DirectorMs. Rachael AndersonGlobal Director of Marketing & Strategic GrowthMr. Jerome WongCorporation Controller, Corp. Sec. & Chief Financial Officer

NASDAQ : EKSO

Ekso Bionics

$10.78

-0.39-3.49%

At Close 4:00 PM

67.67

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Ekso Bionics Holdings, Inc. (EKSO) stock declined over -3.49%, trading at $10.78 on NASDAQ, down from the previous close of $11.17. The stock opened at $11.29, fluctuating between $10.76 and $11.47 in the recent session.

Stock Snapshot

11.17

Prev. Close

26.15M

Market Cap

10.76

Day Low

-2.2

P/E Ratio

-4.91

EPS (TTM)

-0.85

Cash Flow per Share

11.29

Open

2.43M

Number of Shares

11.465

Day High

83.29%

Free Float in %

0.87

Book Value

42.06K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 17, 2026	11.29	11.47	10.76	10.78	42.04K
Mar 16, 2026	11.49	12.30	10.80	11.17	96.9K
Mar 13, 2026	12.03	12.74	11.38	11.56	70.48K
Mar 12, 2026	12.48	12.87	11.60	11.81	82.57K
Mar 11, 2026	12.36	13.50	12.12	12.71	273.48K
Mar 10, 2026	12.00	13.00	12.00	12.40	166.16K
Mar 09, 2026	11.37	12.33	10.76	12.00	136.19K
Mar 06, 2026	10.74	12.47	10.61	11.38	139.19K
Mar 03, 2026	10.01	10.24	10.00	10.00	48.56K
Mar 02, 2026	10.00	10.28	10.00	10.23	45.15K
Feb 27, 2026	9.98	10.23	9.98	10.14	54.51K
Feb 26, 2026	9.75	10.41	9.75	10.02	55.71K
Feb 25, 2026	10.13	10.38	9.64	9.64	73.41K
Feb 24, 2026	10.64	10.87	9.80	10.17	127.4K
Feb 23, 2026	11.42	11.85	10.63	10.64	105.87K
Feb 20, 2026	12.30	12.55	11.16	11.18	130.42K
Feb 19, 2026	12.52	12.88	12.05	12.30	133.13K
Feb 18, 2026	11.25	13.27	11.06	12.95	282.54K
Feb 17, 2026	9.70	11.40	9.60	11.16	223.38K
Feb 13, 2026	9.16	10.17	8.71	9.87	228.33K

Contact Details

San Rafael, CA 94804

United States

https://www.eksobionics.com 510 984 1761

About Company

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. It also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; and EksoUE is a wearable upper extremity assistive device that helps to reduce the effect of gravity on the wearer's shoulders and arms. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in Richmond, California.

Stock Peers

ISRG

-0.7-0.14%

Intuitive Surgical, Inc.$482.76 ATRI

0.26+0.06%

Atrion Corporation$459.92 MASI

0.57+0.32%

Masimo Corporation$175.97 ICUI

3.59+2.83%

ICU Medical, Inc.$130.55 RGEN

4.16+3.61%

Repligen Corporation$119.27 LMAT

1.48+1.34%

LeMaitre Vascular, Inc.$112.23 HOLX

-0.1-0.13%

Hologic, Inc.$75.05 COO

1.01+1.42%

The Cooper Companies, Inc.$72.05 MMSI

1.06+1.53%

Merit Medical Systems, Inc.$70.23 UTMD

0.05+0.08%

Utah Medical Products, Inc.$64.05

Company Overview

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) closed at $10.78 USD, losing -$0.39 (-3.49%) from the previous close of $11.17. The stock is currently mid-range between its 52-week high and low $2.73 and $13.50. With a market capitalization of about $26.15 million, Ekso Bionics Holdings, Inc. is classified as a micro-cap and shows market-like volatility (beta ~0.84). Key stats such as the average daily volume over the past year has been around 2.20 million shares, volume is running light vs its 52-week average. Headquartered in San Rafael, CA, Ekso Bionics Holdings, Inc. operates in the Healthcare sector and the Medical - Instruments & Supplies industry. Led by CEO Scott G. Davis, the company employs approximately 61 people and listed since January 17, 2014. Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally.

Technical Performance

Short-term trend indicators are bearishly aligned (SMA20 -0.63%, SMA50 18.59%, SMA200 88.65%). The stock’s 14-day RSI is 52.04 (neutral), while the ATR of 1.08 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -24.51% below its high and over 267.03% above its low. Average 10-day trading volume of 123.97 thousand shares is below the 3-month average of 2.18 million, indicating normal recent market interest.

Valuation Metrics

Ekso Bionics Holdings, Inc. trades at a P/E ratio of -2.29, slightly below the S&P 500 average, with a price-to-sales ratio of 2.1 and a price-to-book ratio of 2.97 suggesting the stock is closer to book value. The P/FCF stands at -2.27, also above market averages.

Dividend & Fair Value

Ekso Bionics Holdings, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $4.61. This means the shares are trading above this model’s fair value.

Earnings & Analyst Outlook

Ekso Bionics Holdings, Inc. generated EPS of -$5.06 over the past year. Five-year average earnings growth is 31.73%. Wall Street analysts project EPS growth of 80.74% annually over the next five years. Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 2 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $9.50 to $6.00. The high target offers -11.87% upside. The low target suggests -44.34% downside. The mean target is $7.75. This offers -28.11% upside. Ekso Bionics Holdings, Inc. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended October 28, 2025, missed forecasts by 0.0%. The prior quarter beat by 3.33%. Over the last six quarters, Apple has recorded several small beats. These include 18.18% in July 29, 2024.

Shareholding & Insider Activity

Ekso Bionics Holdings, Inc. has 2.61 million shares outstanding. The public float is 2.24 million shares, elevated short interest at 5.40% of float. This equals 138.49 thousand shares. The short ratio is 1.09 days. Institutional investors hold 2.89% of the float. Insiders own 4.95%. Angold Russ holds 391.33 thousand shares, SHERMAN STEVEN has 364.91 thousand shares and ASHER DANIEL has 270.43 thousand shares. Over the past six months, insider transactions show net buying. They sold 47.15 thousand shares across 6 transactions.

Financial & Profitability Overview

Over the trailing twelve months, Ekso Bionics generated $18.28M in revenue, or $1.32 per share. Gross margin was 53.06%, operating margin -82.67%, and net profit margin -83.14%. Returns are negative, with ROA at -52.56% and ROE at -120.56%.
On valuation metrics, Ekso Bionics trades at a P/E of -2.29, P/S of 2.10 and P/B of 2.97. The current ratio is 1.63 and quick ratio is 1.07. Operationally, the company’s inventory turnover is 1.23 and cash conversion cycle is 416.29 days. Debt-to-equity is 0.29, supported by a cash flow-to-debt ratio of -4.48.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, Ekso Bionics posted revenue of $18.28M, down slightly from $12.91M in the prior quarter. Gross profit was $9.70M (margin 53.06%). Operating income was - $15.11M (margin -82.7%). Net income was- $15.20M (EPS - $1.10).
The company ended the quarter with $8.64M in cash and short-term investments, a total debt of $7.17M, and net debt of - $1.47M. Total assets were $28.92M, with equity of $12.61M. Financials further reflected weakness, with operating cash flow of - $12.05M, free cash flow of - $12.21M, and capital expenditures of - $157.00K.

Price Forecast & Outlook

Our AI price prediction model suggests that Ekso Bionics Holdings, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 11.32%, with price expected at $12.00 by March 31, 2026, within a range of $11.06 to $12.95 3-Month Outlook: Projected fall of -92.95%, reaching $0.76 by June 15, 2026, with a range of $0.00 to $3.76. 1-Year Outlook: Projected loss of -100.0%, with price at $0.00 by March 17, 2027, within a range of $0.00 to $6.71.

Key Takeaways

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) shares are flat -4.86% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Ekso Bionics Holdings, Inc. trading at a premium to the broader market with a P/E of -2.29. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $7.00, suggesting -35.06% downside. Our AI forecast model points to short-term strength (11.32% over two weeks), a medium-term fall (-92.95% over three months), and a longer-term loss (-100.0% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Ekso Bionics Holdings, Inc. (EKSO) stock price?

Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) stock price is $10.78 in the last trading session. During the trading session, EKSO stock reached the peak price of $11.47 while $10.76 was the lowest point it dropped to. The percentage change in EKSO stock occurred in the recent session was -3.49% while the dollar amount for the price change in EKSO stock was - $0.39.

EKSO's industry and sector of operation?

The NASDAQ listed EKSO is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector. Ekso Bionics Holdings, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of EKSO?

Mr. Scott W. Davis
Chief Executive Officer
Mr. Anthony Pratt
Vice President of Sales
Ms. Ann Cookson
HR Director
Ms. Foon Lim Chwee
Pres of APAC
Mr. Jason C. Jones
Chief Operating Officer
Mr. Steven A. Sherman
Chairman & Chief Executive Officer
Mr. Stephan Aderhold
Senior Vice President & GM of EMEA
Mr. Scott G. Davis
Chief Executive Officer & Director
Ms. Rachael Anderson
Global Director of Marketing & Strategic Growth
Mr. Jerome Wong
Corporation Controller, Corp. Sec. & Chief Financial Officer

How EKSO did perform over past 52-week?

EKSO's closing price is 294.87% higher than its 52-week low of $2.73 where as its distance from 52-week high of $13.50 is -20.15%.

How many employees does EKSO have?

Number of EKSO employees currently stands at 61.

Link for EKSO official website?

Official Website of EKSO is: https://www.eksobionics.com

How do I contact EKSO?

EKSO could be contacted at phone 510 984 1761 and can also be accessed through its website. EKSO operates from 1414 Harbour Way South, San Rafael, CA 94804, United States.

How many shares of EKSO are traded daily?

EKSO stock volume for the day was 42.06K shares. The average number of EKSO shares traded daily for last 3 months was 2.2M.

What is the market cap of EKSO currently?

The market value of EKSO currently stands at $26.15M with its latest stock price at $10.78 and 2.43M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	61
Beta	0.84
Sales or Revenue	$18.28M
5Y Sales Change%	-0.525%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Instruments & Supplies

EKSO Company Profile and Key Details

Ekso Bionics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Dividend & Fair Value

Company Overview

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Valuation Metrics

Key Takeaways

Price Forecast & Outlook